Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
2.130
+0.010 (0.47%)
At close: Nov 20, 2024, 4:00 PM
2.250
+0.120 (5.63%)
After-hours: Nov 20, 2024, 5:11 PM EST
Alaunos Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -11.78 | -35.14 | -37.73 | -78.75 | -79.98 | -117.8 | |
| Depreciation & Amortization | 0.24 | 2.32 | 2.76 | 2.6 | 1.13 | 0.63 | |
| Other Amortization | - | 1.34 | 0.98 | 0.38 | - | - | |
| Loss (Gain) From Sale of Assets | -0.01 | 0.01 | 0.01 | - | - | - | |
| Asset Writedown & Restructuring Costs | 3.79 | 4.8 | - | 0.74 | - | - | |
| Stock-Based Compensation | 0.6 | 2.8 | 3.53 | 10.77 | 6.83 | 7.34 | |
| Other Operating Activities | -1.1 | -0.01 | 0.35 | -0.35 | - | 60.75 | |
| Change in Accounts Receivable | - | 0 | 1.11 | 3.56 | -1.34 | -1.47 | |
| Change in Accounts Payable | -0.84 | -0.77 | -0.03 | 0.27 | 0.05 | 0.2 | |
| Change in Other Net Operating Assets | -2.68 | -5.48 | -0.21 | -0.69 | 16.29 | 9.49 | |
| Operating Cash Flow | -11.76 | -30.14 | -29.23 | -61.47 | -57.01 | -40.85 | |
| Capital Expenditures | - | -0.2 | -0.22 | -3.32 | -9.78 | -0.28 | |
| Sale of Property, Plant & Equipment | 1.5 | 1.54 | 0.02 | - | - | - | |
| Investing Cash Flow | 1.5 | 1.35 | -0.19 | -3.32 | -9.78 | -0.28 | |
| Long-Term Debt Issued | - | - | - | 25 | - | - | |
| Long-Term Debt Repaid | - | -18.11 | -8.33 | - | - | - | |
| Net Debt Issued (Repaid) | - | -18.11 | -8.33 | 25 | - | - | |
| Issuance of Common Stock | - | 0.09 | 14.75 | 1.04 | 102.12 | 59.8 | |
| Repurchase of Common Stock | - | - | -0.05 | - | - | -0.65 | |
| Other Financing Activities | - | -0.13 | - | -0.26 | - | - | |
| Financing Cash Flow | - | -18.14 | 6.37 | 25.78 | 102.12 | 59.15 | |
| Net Cash Flow | -10.26 | -46.93 | -23.06 | -39.02 | 35.33 | 18.01 | |
| Free Cash Flow | -11.76 | -30.34 | -29.45 | -64.79 | -66.79 | -41.14 | |
| Free Cash Flow Margin | -168057.14% | -606780.00% | -1007.80% | -16279.15% | - | - | |
| Free Cash Flow Per Share | -7.35 | -18.97 | -20.34 | -45.33 | -47.79 | -36.74 | |
| Cash Interest Paid | 4.13 | 2.06 | 2.17 | 0.63 | - | - | |
| Levered Free Cash Flow | -6.08 | -5.1 | -27.95 | -33.39 | -36.02 | -29.4 | |
| Unlevered Free Cash Flow | -6.08 | -5.24 | -26.96 | -33.03 | -36.02 | -29.4 | |
| Change in Net Working Capital | 4.49 | -7.66 | 12.57 | -2.64 | -16.03 | 0.93 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.